News

WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
News-Medical.Net15h
WHO and UNICEF urge action to protect children through vaccines
In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis ...
The world has hit a ‘very stubborn glass ceiling’ on childhood vaccination
An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
News-Medical.Net3d
WHO maintains global emergency status for mpox following June 2025 IHR Emergency Committee meeting
The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...